Multiple companies have confirmed their participation at this point including: DR Healthcare (Spain), AB Biotek Human Nutrition & Health (UK), ABF ingredients (France), Supremex (Hungary), RevivaBio (Sweden), Geneceutica (Romania), Histamed (Germany), S&D Pharma (Slovakia), Miralex (Poland), Designs for Health (USA), Laboratories COPMED (France), DAO Deficiency Clinical Institute (Spain), Tabilaç (Turkey), Intoleran (Netherlands), SYNLAB (Spain), Grupo VIVO (Spain) & Echevarne (Spain).